India's rising batting sensation Yashasvi Jaiswal has taken a U-turn and has requested the Mumbai Cricket Association (MCA) to let him continue with Mumbai and not move to Goa for the 2025-26 domestic season, according to ESPNcricinfo.
In a decisive move to ensure the uninterrupted availability of essential goods, the District Magistrate of U.T. Chandigarh has imposed a ban on hoarding and stockpiling of essential commodities under the Essential Commodities Act, 1955, and Section 163 of the Bhartiya Nagrik Suraksha Sanh
Retired Air Vice Marshal Suryakant Chintaman Chafekar and defence expert Sanjay Kulkarni have provided insights into India's strategic defensive superiority, highlighting the effectiveness of its defence systems in countering Pakistan's tactics.
The indigenously developed Akash surface-to-air missile air defence system has played a crucial role in thwarting Pakistani drone attacks targeting Indian assets on Thursday, according to defence officials.
After Operation Sindoor has been successfully executed by the Indian armed forces leaders from across the political spectrum have voiced strong support for the armed forces and Prime Minister Narendra Modi's response.
Bibiano Fernandes, one of the most successful coaches in Indian men's youth teams' history, having qualified the Blue Colts to three successive AFC U16/17 Asian Cups from 2018 to 2023, is now set to begin a new cycle with a new batch of players. It all starts with the SAFF U19 Championshi
Dubai Police has finalised preparations for the World Police Summit 2025, held under the patronage of His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai.
New Delhi [India], May 7: The Iconic Brand of the Year Award 2025 celebrates the achievements of MSME businesses from across India, recognizing their vital contributions to the nation's economic growth and their role in shaping the vision of Viksit Bharat. The 7th edition of this prestigious
The recent executive orders on pharma issued by President Donald Trump are expected to create significant challenges for Indian pharmaceutical companies, especially those operating in the U.S. generic drug market, according to a report by Nuvama Research.